dicycloverine also known dicyclomine sold brand name bentyl us medication used treat spasms intestines occur irritable bowel taken mouth injection used baby colic enterocolitis evidence support common side effects include dry mouth blurry vision weakness sleepiness serious side effects may include psychosis breathing problems use pregnancy appears safe use breastfeeding works entirely dicycloverine approved medical use united states available generic commonly prescribed medication united states million dicyclomine used treat symptoms irritable bowel syndrome specifically hypermotility clinical guidelines recommended dicycloverine antispasmodics ibs diarrhea first line medicine used people obstructive gi urinary condition severe ulcerative colitis reflux unstable cardiac condition glaucoma myasthenia gravis anyone acutely given children infants colic due risks convulsions difficult breathing irritability little evidence support efficacy use dicycloverine known impair thinking coordination people taking drug avoid driving operating effect baby pregnancy breastfeeding well dicycloverine cause range anticholinergic side effects dry mouth nausea blurred vision dizziness confusion severe constipation stomach pain heart palpitations difficulty urinating dicycloverine blocks action acetylcholine cholinergic receptors smooth muscles gi tract relaxing smooth dicycloverine first synthesized chemically united states circa scientists william merrell first marketed gastrointestinal disorders including colic inn name dicycloverine recommended included combination drug morning sickness called bendectin along doxylamine vitamin launched us dicyclomine removed formulation merrell determined added value bendectin became subject many lawsuits due allegations caused birth defects similar thalidomide merrell also marketed us several governments restricted use infants due reports convulsions difficult breathing irritability restlessness infants given us federal trade commission ordered marion merrell dow recently acquired rugby darby generic manufacturer dicycloverine us promise grant licenses intellectual property drug company wanted based antitrust concerns us market drug time around million dow rugby next year hoechst marion roussel time acquired business granted license endo pharmaceuticals several generic competitors started selling drug case part reshaping us pharmaceutical market occurred favor generic rarely reports dicycloverine abuse dicycloverine antagonist receptor sites though affinities targets roughly onefifth onetenth strong affinities clinical targets also relatively nonpolar tertiary amine able cross bloodbrain barrier leading delirium high httpsenwikipediaorgwikidicycloverine